Greville Investing

Greville Investing is a private investment vehicle and subsidiary of the Royal Golden Eagle (RGE) group, a global conglomerate owned by the Tanoto family. The company is a prominent player in the healthcare services sector, specifically known for its strategic acquisition of a substantial stake in Healius Limited, one of Australia's largest pathology and diagnostic imaging providers. While not a drug developer itself, Greville Investing's capital activities significantly impact the diagnostic healthcare market and corporate consolidation trends. The firm operates as a holding company, leveraging RGE's extensive resources to pursue long-term strategic investments in healthcare infrastructure. Its role is primarily that of a financial and strategic stakeholder rather than a clinical-stage biotechnology entity.